ArticleFrontiers in immunology2025

Discussion on the duration of response following HBsAg clearance in patients with chronic hepatitis B treated with PegIFNα-2b.

Tao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.